Back
Compare AU
Compare OOO vs. CURE
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are OOO and CURE. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.
Community Stats
OOO | CURE | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 96 | 72 |
Median incremental investment | $1,993.50 | $684.93 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,464.32 | $2,314.62 |
Average age group | > 35 | > 35 |
Key Summary
OOO | CURE | |
|---|---|---|
Strategy | OOO.AX was created on 2011-11-11 by BetaShares. The fund's investment portfolio concentrates primarily on crude oil commodities. OOO.AX aims to track the performance of an index (before fees and expenses) that provides exposure to crude oil futures, hedged for currency movements in the AUD/USD exchange rate | CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index. |
Top 3 holdings | Betashares Crude Oil Index Currncy Hdg Complex ETF (100 %) | Apogee Therapeutics Inc (1.61 %) Oruka Therapeutics Inc (1.42 %) Kymera Therapeutics Inc Ordinary Shares (1.41 %) |
Top 3 industries | Health Care (100.00 %) Other (10.24 %) | |
Top 3 countries | United States (96.62 %) United Kingdom of Great Britain and Northern Ireland (1.35 %) Switzerland (1.13 %) | |
Management fee | 0.69 % | 0.45 % |
Key Summary
OOO | CURE | |
|---|---|---|
Issuer | BetaShares | Global X |
Tracking index | S&P GSCI Crude Oil Hedged to AUD Index - AUD | S&P Biotechnology Select Industry |
Asset class | ETF | ETF |
Management fee | 0.69 % | 0.45 % |
Price | $8.67 | $74.56 |
Size | $126.573 million | $49.001 million |
10Y return | -40.49 % | N/A |
Annual dividend/ distribution yield (5Y) | 10.64 % | 0.03 % |
Market | ASX | ASX |
First listed date | 16/11/2011 | 12/11/2018 |
Purchase fee | $6.50 | $6.50 |
Community Stats
OOO | CURE | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 96 | 72 |
Median incremental investment | $1,993.50 | $684.93 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,464.32 | $2,314.62 |
Average age group | > 35 | > 35 |
Pros and Cons
OOO | CURE | |
|---|---|---|
Pros |
|
|
Cons |
|
|
OOO | CURE |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Higher management fee | Lower management fee |
Higher price growth | Lower price growth |
Higher distribution yield | Lower distribution yield |